Home  | News

27.01.2026

Teaser image to Fabian Theis Speaks at DLD Munich 2026

Fabian Theis Speaks at DLD Munich 2026

From Models to Medicines: AI-Guided Experimental Biology

We are pleased to share that our PI Fabian Theis contributed to DLD Conference 2026 as part of the BIOSPHERE Health Track.

Fabian gave a talk titled “From Models to Medicines: AI-guided Experimental Biology”, focusing on how AI supports biological research and drug discovery. In addition, he joined the panel discussion “From the Cell to Clinical Application”, addressing the translation of AI-driven insights from basic research into clinical practice.

Both sessions are now available as part of the DLD Conference video series.

#event #research #theis
Subscribe to RSS News feed

Related

Link to Needle in a Haystack: Finding Exact Moments in Long Videos

05.02.2026

Needle in a Haystack: Finding Exact Moments in Long Videos

ECCV 2024 research introduces RGNet, an AI model that finds exact moments in long videos using unified retrieval and grounding.

Read more
Link to Benjamin Busam Leads Design of Bavarian Earth Observation Satellite Network “CuBy”

04.02.2026

Benjamin Busam Leads Design of Bavarian Earth Observation Satellite Network “CuBy”

Benjamin Busam leads the scientific design of the “CuBy” satellite network, delivering AI-ready Earth observation data for Bavaria.

Read more
Link to Cracks in the foundations of cosmology

30.01.2026

Cracks in the Foundations of Cosmology

Daniel Grün examines cosmological tensions that challenge the Standard Model and may point toward new physics.

Read more
Link to How Machines Can Discover Hidden Rules Without Supervision

29.01.2026

How Machines Can Discover Hidden Rules Without Supervision

ICLR 2025 research shows how self-supervised learning uncovers hidden system dynamics from unlabeled, high-dimensional data.

Read more
Link to Matthias Nießner Co-Founds AI Startup Synthesia

28.01.2026

Matthias Nießner Co-Founds AI Startup Synthesia

Julien Gagneur comments on DeepMind’s AlphaGenome, highlighting its precision and remaining challenges in genome prediction.

Read more
Back to Top